DISCLOSURE
The authors declare no conflict of interest.
REFERENCES
- Seite S, Flores GE, Henley JB, et al. Microbiome of affected and unaffected skin of patients with atopic dermatitis before and after emollient treatment. J Drugs Dermatol. 2014;13(11):1365-72.
- Kaufam BP, Guttman-Yassky E, Alexis AF. Atopic dermatitis in diverse racial and ethnic groups -- Variations in epidemiology, genetics, clinical presentation and treatment. Exp Dermatol. 2018;27(4):340-357.
- Merriman JA, Mueller EA, Cahill MP, et al. Temporal and racial differences associated with atopic dermatitis staphylococcus aureus and encoded virulence factors. mSphere. 2016;1(6):e00295-16.
- Hirano SA, Murray SB, Harvey VM. Reporting, Representation, and subgroup analysis of race and ethnicity in published clinical trials of atopic dermatitis in the United States Between 2000 and 2009. Pediatr Dermatol. 2012;29(6):749-5.
- Zelenkova H, Kerob D, Salah S, et al. Impact of daily use of emollient 'plus' on corticosteroid consumption in patients with atopic dermatitis: An open, randomized controlled study. J Eur Acad Dermatol Venereol. 2023:37 Suppl 5:27-34.
AUTHOR CORRESPONDENCE
Hawasatu Dumbuya PhD hawasatu.dumbuya@loreal.com